Mount Sinai Alzheimer's Disease Research Center

New York, New York 10029

We've found

2 trials

at this facility

Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

New York, NY

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease

Status: Enrolling, Phase II
Updated: 12/31/1969

from

New York, NY

Use our guide to learn which trials are right for you!